|
original article |
Journal |
Date |
Title |
Authors Max. 6 Authors |
1 |
[GO] |
Eurasian Journal of Applied Biotechnology |
2024―Oct―29 |
INFLUENCE OF PHYSICOCHEMICAL FACTORS ON THE SARS-COV-2 STRAIN ISOLATED FROM A DOG |
S.O. Sadikaliyeva, E.Zh. Kalimolda, Zh.S. Abay, Ye.A. Shayakhmetov, S.U. Moldagulova, K.A. Shorayeva, K.K. Jekebekov, A.D. Omurtay, A.T. Zhunushov, N.S. Kozhabergenov, B.A. Yespembetov, M.M. Kassenov, A.S. Nurpeisova |
2 |
[GO] |
Eurasian Journal of Applied Biotechnology |
2024―Sep―18 |
SARS-COV-2 CORONAVIRUS ANTIGENS MODULATE THE ACTIVITY OF HUMAN T-REGULATORY CELLS |
S.A. Kan, A.V. Lushova, N. Abdolla, R. Tleulieva, Y.V. Perfilyeva, Y.O. Ostapchuk |
3 |
[GO] |
Eurasian Journal of Applied Biotechnology |
2024―Sep―18 |
ПРИМЕНЕНИЕ MALDI-TOF-MS И МАШИННОГО ОБУЧЕНИЯ ДЛЯ SARS-COV-2 И ДРУГИХ РЕСПИРАТОРНЫХ ИНФЕКЦИЙ |
И.А. Кадырова, А.А. Султанбекова |
4 |
[GO] |
Eurasian Journal of Applied Biotechnology |
2024―Sep―18 |
THE RECOMBINANT BACTERIA LACTOCOCCUS LACTIS EXPRESSING SARS-COV-2 SPIKE PROTEIN OR ITS RECEPTOR-BINDING DOMAIN ELICITS AN IMMUNE RESPONSE FOLLOWING ORAL IMMUNISATION OF RATS |
O.V. Evdokimova, A.E. Akhremchuk, L.N. Valentovich, O.E. Soboleva, S.V. Gubkin |
5 |
[GO] |
Eurasian Journal of Applied Biotechnology |
2024―Jul―05 |
Targeted in vitro- confirmation of the antiviral activity of Tenvir (Tenofovir) drug against the SARS-COV-2 virus variant B. in Kazakhstan and identifying NSP12 in the viral genome |
S. Khaidarov, Y. Burashev, N. Kozhabergenov, B. Usserbayev, A. Melisbek, M. Shirinbekov, A. Moldakaryzova, A. Beisenova, A. Mustafaeva, A. Kydyrbaeva |
6 |
[GO] |
Eurasian Journal of Applied Biotechnology |
2024―Apr―04 |
SUPPRESSOR CELLS (MDSC) REGULATE THE T-CELL RESPONSE IN OLD MICE IMMUNIZED WITH THE WHOLE-VIRION SARS-CoV-2 VACCINE |
Y.V. Perfilyeva, N. Abdolla, A. Kali, R. Tleulieva, D. Aben, Y. Abdusattarova, A. Lushova, Ye. Ostapchuk, B. Karalnik, N. Belyaev |
7 |
[GO] |
Eurasian Journal of Applied Biotechnology |
2023―Dec―28 |
STANDARTIZATION OF IMMUNOGENICITY OF INACTIVATED VACCINE QAZVAC AGAINST CORONAVIRUS INFECTION COVID-19 FROM AN EPIDEMIOLOGICALLY RELEVANT STRAIN |
B.Sh. Myrzakhmetova, G.A. Zhapparova, K.B. Bissenbayeva, A.S. Toytanova, M.S. Tuyskanova, G.D. Nakhanova, S.Sh. Nurabayev, K.D. Zhugunissov, L.B. Kutumbetov |
8 |
[GO] |
Eurasian Journal of Applied Biotechnology |
2023―Oct―16 |
CO-INFECTION WITH COVID-19 AND GENETIC DIVERSITY OF SARS-COV-2 IN CHILDREN |
D. Kamalova, M. Makibayeva, A. Amirgazin, S. Abdrakhmanova, I. Sytnik, A. Tuleubaeva, E Ramankulov, A. Shevtsov |
9 |
[GO] |
Eurasian Journal of Applied Biotechnology |
2023―Apr―13 |
POSSIBILITIES OF USING MEDICINES AND BIOLOGICALLY ACTIVE SUBSTANCES AS CORRECTIVES FOR THE FORMATION OF PULMONARY FIBROSIS DURING SARS-COV-2 INFECTION AND IN THE POST-COVID PERIOD |
Z.T. Shulgau, Y.K. Kamyshanskiy, A.Y. Gulyayev |
10 |
[GO] |
Eurasian Journal of Applied Biotechnology |
2023―Apr―13 |
BIOLOGICAL FEATURES OF THE SARS-COV-2 VIRUS FROM DOMESTIC ANIMALS IN THE TERRITORY OF THE RK |
S.O. Sadikalieva, E.A. Shayakhmetov, A.S. Nurpeisova, K.A. Shoraуeva, Zh.S. Abay, A.D. Omurtaу, S.K. Kopeev, A.K. Nakhanov, A.A. Terebay, B.Sh. Myrzakhmetova, N.S. Kozhabergenov, Ye.O. Abduraimov |
11 |
[GO] |
Eurasian Journal of Applied Biotechnology |
2022―Sep―16 |
INHIBITORY ACTIVITY OF ARTEMISIA ANNUA L. EXTRACTS AGAINST SARS-COV-2 CORONAVIRUS |
M. Zhurinov, A. Miftakhova, A. Shustov, V. Keyer, E. Solodova |
12 |
[GO] |
Eurasian Journal of Applied Biotechnology |
2022―Sep―16 |
THE PLANT ARTEMISIA ANNUA (“SWEET WORMWOOD”) KAZAKHSTAN’S SOURSE OF BIOACTIVE COMPOUNDS POTENTIALLY CURE THE SARS-CoV-2 INFECTION |
A. Maftakhova, L. Syzdykova, V. Keer, A. Shustov, M. Zhurinov |
13 |
[GO] |
Eurasian Journal of Applied Biotechnology |
2022―Jul―09 |
NUCLEOSIDE ANALOG FAVIPIRAVIR IS A POOR INHIBITOR AGAINST THE SARS-COV-2 VIRUS IN CELL CULTURE, BUT FAVIPIRAVIR IS HIGHLY ACTIVE AGAINST VENEZUELAN EQUINE ENCEPHALITIS VIRUS |
G.M. Zauatbayeva, L.R. Syzdykova, V.V. Keyer, A.V. Shustov, A.Z. Abilmagzhanov, M.Zh. Zhurynov |
14 |
[GO] |
Eurasian Journal of Applied Biotechnology |
2022―Jan―12 |
CRISPR/CAS12A-BASED DIAGNOSTICS FOR COVID-19 |
A. Kabylbayeva, K. Zharylgassynova, A. Abilova, M. Amanzholova, S. Abeldenov |